Biggest News aggregator with 200 million news articles | vimarsana.com

it can turn it into a vapor. the problem is that this drug, until recently, was manufactured by three companies in the united states. one of those companies was shut down basically for manufacturing issues. as you said, acorn pharmaceuticals that was manufacturing albuterol shut down their illinois plant after they declared bankruptcy. that was the plant that manufactured this agent. that leaves only one company in the united states to produce albuterol. there are 25 million people in this country with asthma. there are about a million and a half e.r. visits every year for this very common issue. it kills 4,000 people a year. almost all those deaths are preventible. this is a crucial drug. it sort of underscores the fragility of the u.s. drug generic pipeline. >> can we get into a situation where there are shortages because people are trying to get as much of this albuterol that

Related Keywords

Drug , U S , Problem , One , Companies , Manufacturing , Vapor , Three , Company , Plant , Acorn Pharmaceuticals , Manufacturing Albuterol , Issues , Bankruptcy , Agent , Illinois , People , Country , Albuterol , Issue , Asthma , Half , A Million , 4000 , 25 Million , It , Situation , Fragility , Shortages , Deaths , Preventible , Generic Pipeline ,

© 2024 Vimarsana